The Journal of Thoracic and Cardiovascular Surgery
Volume 136, Issue 5 , Pages 1149-1155, November 2008

Influence of preoperative renal dysfunction on one-year bypass graft patency and two-year outcomes in patients undergoing coronary artery bypass surgery

  • Rajendra H. Mehta, MD, MS

      Affiliations

    • Duke Clinical Research Institute and Duke University Medical Center, Durham, NC
    • Corresponding Author InformationAddress for reprints: Rajendra H. Mehta, MD, MS, Box 17969, Duke Clinical Research Institute, Durham, NC 27715.
    • ,
  • Gail E. Hafley, MS

      Affiliations

    • Duke Clinical Research Institute and Duke University Medical Center, Durham, NC
    • ,
  • C. Michael Gibson, MD

      Affiliations

    • Beth Israel Deaconess Medical Center, Boston, Mass
    • ,
  • Robert A. Harrington, MD

      Affiliations

    • Duke Clinical Research Institute and Duke University Medical Center, Durham, NC
    • ,
  • Eric D. Peterson, MD, MPH

      Affiliations

    • Duke Clinical Research Institute and Duke University Medical Center, Durham, NC
    • ,
  • Michael J. Mack, MD

      Affiliations

    • Medical City Hospital, Dallas, Tex
    • ,
  • Nicholas T. Kouchoukos, MD

      Affiliations

    • Missouri Baptist Medical Center, St Louis, Mo
    • ,
  • Robert M. Califf, MD

      Affiliations

    • Duke Clinical Research Institute and Duke University Medical Center, Durham, NC
    • ,
  • T. Bruce Ferguson Jr., MD

      Affiliations

    • East Carolina University, Greenville, NC
    • ,
  • John H. Alexander, MD, MHS

      Affiliations

    • Duke Clinical Research Institute and Duke University Medical Center, Durham, NC
    • ,
  • Project of Ex-vivo Vein Graft Engineering via Transfection (PREVENT)-IV Investigators

Received 21 August 2007; received in revised form 12 December 2007; accepted 19 February 2008. published online 28 August 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 The Prevent-IV trial was funded by Corgentech Inc, South San Francisco, Calif. Dr Mehta is funded by the Duke Clinical Research Institute, Durham, NC.

PII: S0022-5223(08)01090-8

doi:10.1016/j.jtcvs.2008.02.085

The Journal of Thoracic and Cardiovascular Surgery
Volume 136, Issue 5 , Pages 1149-1155, November 2008

Article Tools

* Image Usage & Resolution